Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug trial aims to find safe dose for advanced breast cancer

NCT ID NCT02926690

Recruiting now Disease control Sponsor: OncoTherapy Science, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study is testing a new drug called OTS167PO in people with advanced breast cancer that has come back or spread. The main goal is to find the safest dose and understand side effects. About 70 women aged 18 and older will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY LOCALLY ADVANCED OR METASTATIC BREAST CANCER AND TRIPLE NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm Recurrence triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RELAPSED/REFRACTORY LOCALLY ADVANCED OR METASTATIC BREAST CANCER AND TRIPLE NEGATIVE BREAST CANCER

Contacts and locations

Locations

  • Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center

    RECRUITING

    Lebanon, New Hampshire, 03756, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Emory University, Winship Cancer Institute

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Froedtert Hospital & the Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kapi'olani Medical Center for Women & Children

    RECRUITING

    Honolulu, Hawaii, 96826, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • MD Anderson Cancer Center

    COMPLETED

    Houston, Texas, 77030, United States

  • Memorial Sloan Kettering Cancer Center

    COMPLETED

    New York, New York, 11065, United States

  • Norwalk Hospital

    COMPLETED

    Norwalk, Connecticut, 06856, United States

  • Weill Cornell Medicine | NewYork-Presbyterian

    COMPLETED

    New York, New York, 10065, United States